HOLX - Hologic secures European CE mark for use of saliva samples with COVID-19 test

Hologic (HOLX) has obtained a CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in Europe.The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19. The test runs on the fully automated Panther system. The availability of this alternative specimen type should help facilitate screening in schools, workplaces and other settings.The Aptima SARS-CoV-2 assay is also CE-marked for use with nasopharyngeal and nasal swabs as well as additional specimen types. Hologic has expanded manufacturing capability to produce Aptima tests in large quantities and has shipped more than 100M Aptima COVID-19 tests globally since the spring of 2020.

For further details see:

Hologic secures European CE mark for use of saliva samples with COVID-19 test